top of page
New Data Shows More Life Sciences Research Programs and Drugs Are Being Discontinued
We recently tallied six new entries for our Life Sciences Investment Tracker , identifying four more research programs and two more drugs...
Incubate Coalition
Mar 5
Incubate Featured in STAT's Coverage of the EPIC Act Introduction
STAT reporter Ed Silverman recently interviewed Incubate's execute director John Stanford for an article on the EPIC Act's...
Incubate Coalition
Mar 5
Incubate applauds reintroduction of bipartisan EPIC Act
WASHINGTON, D.C. (February 25) -- Today, Representative Greg Murphy, Representative Don Davis, and Representative Richard Hudson...
Incubate Coalition
Feb 25
Defending Innovation: Why the 2025 Special 301 Report Must Take a Stand
Incubate has urged Congress to take action and ensure the 2025 Special 301 Report reaffirms America’s commitment to safeguarding...
Incubate Coalition
Feb 19
Incubate Responds to Next 15 Drugs Selected for Medicare Price Controls
WASHINGTON (January 17) -- Today, the Centers for Medicare & Medicaid Services announced the second round of Medicare Part D drugs...
Incubate Coalition
Jan 17
bottom of page